Navigation Links
NIOXIN(R) Research Laboratories First to Market HairDX Genetic Test for Women's Hair Loss
Date:4/23/2008

Online Availability Allows Women to Privately Test for Hair Loss

LITHIA SPRINGS, Ga., April 23 /PRNewswire/ -- NIOXIN(R) Research Laboratories, the leader in professional skincare for the scalp, has entered into an agreement with HairDX, LLC to market the world's first genetic test for predicting female hair loss. NIOXIN(R), known throughout the industry as a force in the thinning hair category, will market this test to consumers through multiple vehicles including professional salons and beauty stores.

Today's launch offers a chance at prevention for women at risk of losing their hair. The easy to understand test provides an accurate and understandable genetic analysis of a woman's likelihood of developing a common type of hair loss called Female Androgenetic Alopecia.

Scientists have identified markers associated with female hair loss and the test uses these markers to provide women with insight into their potential for hair loss. By providing a score called the CAG repeat score, a woman can learn about her likelihood of hair loss. A smaller CAG repeat score is associated with a higher risk for significant hair loss, also known as Ludwig grade II or III hair loss, while a larger repeat score is associated with a lower risk for hair loss.

"Scientists discovered that the percentage of the female population with a CAG repeat length of 15 or less, NOT suffering from a Ludwig grade II or III hair loss was only 2.3%," says Dr. Nathan Vandergraft, a Statistician and Research Scientist at the University of California, Irvine.

"NIOXIN is pleased to join forces with HairDX to be the first to bring this innovative technology to market for the benefit of women around the world who experience hair loss and seek a greater understanding of this issue. This is a highly sensitive concern for women and we take great pride in empowering them with valuable information in a format that ensures confidentiality," says Brian Graham, CEO of NIOX
'/>"/>

SOURCE NIOXIN(R) Research Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Researchers Identify Contaminant in Tainted Heparin
2. UMass Medical School researchers awarded pediatric HIV vaccine development grant
3. Researchers identify new cell targets for preventing growth of breast and other tumors
4. Best Practice Database Adds New Research on Effective Sales Force Incentives and Continuing Medical Education
5. NIAID describes research priorities to fight drug-resistant tuberculosis
6. OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival
7. Melanoma lurks in larger skin lesions, NYU researchers find
8. Eularis to Address Making the Right Research Decision for ROI
9. New Word of Mouth Research Finds Moms Buzzing About Brands
10. Creating an Effective Market Research Group to Generate High-Impact Business Results
11. Life Sciences Fund grants awards to launch health research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Woodloch Pines, an ... has been selected by TripAdvisor as the number one best ... 6th best in the world for their annual Travelers’ Choice ... travel community . The website is home to millions of ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The Incredible Bulk ... Ben Pakulski to increase lean muscle by up to 30lbs ... caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative ... it is a step-by-step, scientific diet formula that allows the ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... number one in the nation in cardiology and GI ... for 2008, BOSTON, May 29 Children,s Hospital ... pediatric hospitals in the country,according to U.S.News & World ... Since the magazine began ranking hospitals 19 years ago, ...
... 5; Cancer program ... in Top 10 ... Bay Area, STANFORD, Calif., May 29 Once again, Lucile Packard,Children,s Hospital ... annual America,s Best Children,s Hospitals issue hitting,newsstands June 2, the magazine places Lucile ...
... to 66% increased risk of disease after operation , , ... anti-rejection drug sirolimus may lead to increased risk of ... data on about 20,000 Medicare patients who had kidney ... patients had diabetes before their kidney transplant. Compared to ...
... Sales Managers and executives,often face questions such as: ... middle-ranking performers, Inducements have to stand out to,engender ... is a summary of a research,presentation that evaluates ... and intangible rewards used in sales recognition programs. ...
... 1 or type 2 diabetes who self-monitor their blood ... adjust treatment regimens can achieve improved glucose control, according ... Special Supplement to the June 2008 issue (Volume 10, ... journal published by Mary Ann Liebert, Inc. ( www.liebertpub.com ...
... May 29 Martek Biosciences,Corporation (Nasdaq: MATK ) ... Annual Needham & Company Biotechnology and Medical Technology,Conference in ... - 12, 2008 at,the New York Palace Hotel. Peter ... 12, 2008 at 1:30 p.m. Eastern Time., A ...
Cached Medicine News:Health News:Children's Hospital Boston Ranked Number One in New England 2Health News:Children's Hospital Boston Ranked Number One in New England 3Health News:U.S.News 2008 'Best Hospitals' Issue Again Ranks Packard Children's as One of Nation's Best 2Health News:Anti-Rejection Drug May Boost Diabetes in Kidney Transplant Patients 2Health News:Best Practices in Sales Recognition 2Health News:Special supplement on self-monitoring of blood glucose in diabetes technology & therapeutics 2
(Date:1/23/2015)... HILL, N.C. , Jan. 23, 2015 For the ... are in dealing with payers. Likewise, the importance of the ... - will only continue to grow as payer formularies and ... access therapies. At the same time, managed markets ...
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ... "Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends ... Video communication has been the topic of fascination ... the United States and the Soviet Russia. Earlier ...
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ... the "Urinary Catheters Market (Indwelling or Foley Catheters, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... , At present, the global market for ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3
... Data Show Bifeprunox Maintained Stability,Significantly Longer than ... Profile Comparable with Placebo , MARIETTA, Ga. ... Solvay,Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of ... results on,bifeprunox, an investigational treatment for adult ...
... 2007 /PRNewswire-FirstCall/ -- Forest,Laboratories, Inc. and Cypress ... from a 1,196 patient randomized,three month, double-blind, ... therapeutic effects of,milnacipran as a treatment of ... only been able to review initial top-line,results ...
Cached Medicine Technology:New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 2Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 3Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 4Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 5Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome 6
... blood oximeters provide cardiologists with critical ... a patient's blood. The Oxicom series ... over a half-million saturation samples measured ... cost-effective oxygen saturation readings in less ...
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
Medicine Products: